Featured News

Featured posts

Latest News

Case Study 1

Company profile: USA NASDAQ-listed biotech Phase: 1a SAD MAD & 1b Therapeutic Area: Psychedelic Neuroscience

iNGENuCRO_Depression_WP_Excessive_placebo_DL

Case Study 2

Company profile: USA NASDAQ-listed biotech Phase: 1a SAD MAD & 1b Therapeutic Area: Psychedelic Neuroscience

iNGENuCRO_Depression_WP_TRD_Failures_DL

Case Study 3

Company profile: USA NASDAQ-listed biotech Phase: 1a SAD MAD & 1b Therapeutic Area: Psychedelic Neuroscience